Faisal Ghiath Sukhtian

Insider Reports History

Location
Amman, Jordan
Signature
/s/Lawrence A. Kenyon, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Faisal Ghiath Sukhtian:

Company Role Class Num Shares Value Price $ Report Date Ownership
Outlook Therapeutics, Inc. Director Stock Option (Right to Buy) 117,296 03 Oct 2025 Direct

Insider Reports Filed by Faisal Ghiath Sukhtian

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OTLK Outlook Therapeutics, Inc. 01 Oct 2025 2 $0 4 Director 03 Oct 2025, 18:52
OTLK Outlook Therapeutics, Inc. 04 Feb 2025 1 $0 4 Director 06 Feb 2025, 16:40
OTLK Outlook Therapeutics, Inc. 01 Oct 2024 3 $0 4 Director 03 Oct 2024, 20:30
OTLK Outlook Therapeutics, Inc. 07 Mar 2024 1 $0 4 Director 08 Mar 2024, 16:08
OTLK Outlook Therapeutics, Inc. 04 Oct 2023 1 $0 4 Director 05 Oct 2023, 17:06
OTLK Outlook Therapeutics, Inc. 29 Mar 2023 1 $0 4 Director 31 Mar 2023, 17:45
OTLK Outlook Therapeutics, Inc. 07 Oct 2022 1 +$38,700 4 Director 11 Oct 2022, 17:09
OTLK Outlook Therapeutics, Inc. 05 Oct 2022 1 $0 4 Director 07 Oct 2022, 16:33
OTLK Outlook Therapeutics, Inc. 21 Apr 2022 1 $0 4 Director, 10%+ Owner 22 Apr 2022, 16:38
OTLK Outlook Therapeutics, Inc. 23 Mar 2022 1 $0 4 Director 24 Mar 2022, 17:40
OTLK Outlook Therapeutics, Inc. 02 Dec 2021 1 +$25,200 4 Director 02 Dec 2021, 16:08
OTLK Outlook Therapeutics, Inc. 05 Oct 2021 1 $0 4 Director 07 Oct 2021, 17:05